Keros Therapeutics (KROS) Enterprise Value (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Enterprise Value (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58.56% |
| Sep 30, 2025 | -0.47% |
| Jun 30, 2025 | 4.21% |
| Mar 31, 2025 | -28.68% |
| Dec 31, 2024 | -5.51% |
| Sep 30, 2024 | -30.75% |
| Jun 30, 2024 | 8.27% |
| Mar 31, 2024 | -33.61% |
| Dec 31, 2023 | -15.02% |
| Sep 30, 2023 | 10.60% |
| Jun 30, 2023 | 8.37% |
| Mar 31, 2023 | -25.94% |
| Dec 31, 2022 | -16.55% |
| Sep 30, 2022 | -11.04% |
| Jun 30, 2022 | 5.67% |
| Mar 31, 2022 | 0.63% |
| Dec 31, 2021 | -3.93% |
| Sep 30, 2021 | 6.65% |
| Jun 30, 2021 | 7.09% |
| Mar 31, 2021 | 4.01% |